Journal of Clinical Densitometry
Volume 9, Issue 2 , Pages 154-158 , April 2006

Inhaled Steroids Do Not Decrease Bone Mineral Density But Increase Risk of Fractures: Data from the GIUMO Study Group

Received 22 July 2005 ,Revised 25 October 2005 ,Accepted 27 November 2005.

References 

  1. Lemiere C, Bai T, Balter M, et al. 2004 Adult Asthma Consensus Guidelines Update. Can Respir J. 2003;11(Suppl A):9A–18A
  2. Leone FT, Fish JE, Szefler SJ, West SL. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest. 2003;124:2329–2340
  3. Nelson HS. Combination therapy of long-acting beta agonists and inhaled corticosteroids in the management of chronic asthma. Curr Allergy Asthma Rep. 2005;5:123–129
  4. Ebeling PR, Erbas B, Hopper JL, Wark JD, Rubinfeld AR. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Miner Res. 1998;13:1283–1289
  5. Tug T, Kamanli A, Tug E. Effects of long-term inhaled steroid use on bone mineral density in asthma patients. J Investig Allergol Clin Immunol. 2001;11:300–302
  6. Harmanci E, Colak O, Metintas M, Alatas O, Yurdasiper A. Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma. Allergol Immunopathol (Madr). 2001;29:22–27
  7. Sivri A, Coplu L. Effect of the long-term use of inhaled corticosteroids on bone mineral density in asthmatic women. Respirology. 2001;6:131–134
  8. Fujita K, Kasayama S, Hashimoto J, et al. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res. 2001;16:782–787
  9. Sambrook PN. Inhaled corticosteroids, bone density, and risk of fracture. Lancet. 2000;355:1385
  10. Smith BJ, Phillips PJ, Heller RF. Asthma and chronic obstructive airway diseases are associated with osteoporosis and fractures: a literature review. Respirology. 1999;4:101–109
  11. World Health Organisation Scientific Group Research on the menopause . WHO Technical Services Report Series 670. Geneva: WHO; 1998;
  12. Díaz Curiel M, Carrasco de la Peña JL, Honorato Pérez J, Pérez Cano R, Rapado A, Ruiz Martínez I. Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Osteoporos Int. 1997;7:59–64
  13. Sosa M, Saavedra P, Muñoz-Torres M, et al. Quantitative ultrasound calcaneus measurements: normative data and precision in Spanish population. Osteoporos Int. 2002;13:487–492
  14. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999;159:941–955
  15. Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J. 2003;46(Suppl):64s–75s
  16. Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003;114:10–14
  17. Ishizuka T, Yoshii A, Hisada T, et al. Effects of fluticasone propionate on bone mineral density in patients with persistent bronchial asthma. Intern Med. 2002;41:798–804
  18. Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J. 1986;293:1463–1466
  19. Packe GE, Douglas JG, McDonald AF, Robins SP, Reid DM. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax. 1992;47:414–417
  20. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001;345:941–947
  21. Medici TC, Grebski E, Hacki M, Ruegsegger P, Maden C, Efthimiou J. Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects. Thorax. 2000;55:375–382
  22. Luengo M, del Rio L, Pons F, Picado C. Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. Eur Respir J. 1997;10:2110–2113
  23. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999;159:941–955
  24. Halpern MT, Schmier JK, Van Kerkhove MD, Watkins M, Kalberg CJ. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. Ann Allergy Asthma Immunol. 2004;92:201–207
  25. Cummings SR, Black D. Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. Am J Med. 1995;98(2A):24S–28S
  26. van Staa TP, Dennison EM, Leufkens HG, Cooper C. Epidemiology of fractures in England and Wales. Bone. 2001;29:517–522
  27. Melton LJ, Patel A, Achenbach SJ, Oberg AL, Yunginger JW. Long-term fracture risk following adult-onset asthma: a population-based study. Osteoporos Int. 2004;15:311–316
  28. Melton LJ, Patel A, Achenbach SJ, Oberg AL, Yunginger JW. Long-term fracture risk among children with asthma: a population-based study. J Bone Miner Res. 2005;20:564–570
  29. Johnell O, Pauwels R, Löfdahl C-G, et al. Bone mineral density in patients with chronic onstructive pulmonary disease treated with budesonide Turbuhaler®. Eur Respir J. 2002;19:1058–1063
  30. Suissa S, Baltzan M, Kremer R, Ernst P. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med. 2004;169:83–88

PII: S1094-6950(06)00016-3

doi: 10.1016/j.jocd.2005.11.005

Journal of Clinical Densitometry
Volume 9, Issue 2 , Pages 154-158 , April 2006

Article Tools

* Image Usage & Resolution